Skip to main content

Acid Sphingomyelinase from Human Urine: Purification and Characterisation

  • Conference paper
Lipid Storage Disorders

Part of the book series: NATO ASI Series ((NSSA,volume 150))

  • 112 Accesses

Abstract

Acid sphingomyelinase (sphingomyelin phosphodiesterase, EC 3.1.4.12) was purified from human urine in the presence of 0.1 % Nonidet P-40. The activity could be enriched up to 30 000 fold by sequential chromatography on Octyl-Sepharose, Concanavalin-A Sepharose, Blue Sepharose and DEAE Cellulose. The last purification step yielded an enzyme preparation with a specific activity of about 2.5–10 mmol sphingomyelin cleaved/h per mg protein and with a yield of about 3–16 %. Purified sphingomyelinase appeared to be homogeneous in sodium dodecyl sulphate Polyacrylamide gel electrophoresis with a mass of about 70 kDa. In the presence of 0.08 % sodium taurodeoxycholate the preparation showed phosphodiesterase activity towards several phospholipids. Sphingomyelin, phosphatidylcholine, phosphatidylglycerol and at a slow rate phosphatidylethanolamine, phosphatidylinositol and phosphatidylserine were hydrolysed. The phospholipase C activity towards phosphatidylcholine and phosphatidylglycerol and acid sphingomyelinase activity copurified during the entire purification procedure, indicating that acid sphingomyelinase has phospholipase C activity towards these lipids.

Addition of 100 µM tripalmitoylglycerol to the assay system (which contains 100 µM sphingomyelin) instead of detergent, stimulated the reaction about 20-fold, thus offering a sensitive system for the assay of acid sphingomyelinase in a system free of detergents. Sphingomyelin degradation was strongly inhibited by phosphatidylinositol 4′, 5′-bis phosphate, adenosine 3′, 5′- diphosphate and adenine-9-β-D arabinofuranoside 5′-monophosphate (50 % inhibition at inhibitor concentrations of 1–5 µM and a substrate concentration of 100 µM sphingomyelin).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J. N. Kanfer, O. Young, D. Shapiro and R. O. Brady, The metabolism of sphingomyelin. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue. J. B. C. 241:1081 (1966).

    CAS  Google Scholar 

  2. P. G. Pentchev, R. O. Brady, A. E. Gal and S. R. Hibbert, The isolation and characterisation of sphingomyelinase from human placental tissue, Biochim. Biophys. Acta 488:312 (1977).

    PubMed  CAS  Google Scholar 

  3. C. S. Jones, P. Shankaran and J. W. Callahan, Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography, Biochem. J. 195:373 (1981).

    PubMed  CAS  Google Scholar 

  4. N. Sakuragawa, Acid sphingomyelinase of human placenta: Purification, properties and 125iodine labeling, J. Biochem. 92:637 (1982).

    PubMed  CAS  Google Scholar 

  5. T. Yamanaka and K. Suzuki, Acid sphingomyelinase of human brain: purification to homogeneity, J. Neurochem. 38:1753 (1982).

    Article  PubMed  CAS  Google Scholar 

  6. R. O. Brady, J. N. Kanfer, M. B. Mock and D. S. Fredrickson, The metabolism of sphingomyelin. Evidence of an enzymatic defect in Niemann-Pick disease, PNAS 55:366 (1966).

    Article  PubMed  CAS  Google Scholar 

  7. P. B. Schneider and E. P. Kennedy, Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J. Lip. Res. 8:202 (1967).

    CAS  Google Scholar 

  8. A. L. Beaudet, M. S. Hampton, K. Patel and J. T. Sparrow, Acidic phospholipases in cultured human fibroblasts. Deficiency of phospholipase C in Niemann-Pick disease. Clin. Chim. Acta 108:403 (1980).

    Article  PubMed  CAS  Google Scholar 

  9. J. R. Wherrett and S. Huterer, Deficiency of taurocholate-dependent phospholipase C acting on phosphadidylcholine in Niemann-Pick disease, Neurolchem. Res. 8, No 1: 89 (1983).

    Google Scholar 

  10. S. Huterer, J. R. Wherrett, A. Poulos and J. W. Callahan, Deficiency of phospholipase C acting on phosphatidylglycerol in Niemann-Pick disease, Neurology 33:67 (1983).

    PubMed  CAS  Google Scholar 

  11. S. F. Freeman, P. Shankaran, S. L. Wolfe and J. W. Callahan, Phosphatidylcholine and 4-methylumbelliferyl phosphorylcholine hydrolysis by purified placental sphingomyelinase, Can. J. Biochem. Cell Biol. 63:272 (1985).

    Article  PubMed  CAS  Google Scholar 

  12. G. Weitz, T. Lindl, U. Hinrichs and K. Sandhoff, Release of sphingomyelin phosphodiesterase (acid sphingomyelinase) by ammonium chloride from CL 1 D Mouse L-Cells and human fibroblasts, Hoppe-Seyler1s Z. Physiol. Chem. 364:863 (1983).

    Article  CAS  Google Scholar 

  13. D. Scidel, J. Klenke, G. Fischer and H. Pilz, An improved and simple micro-method of sphingomyelinase assay in leukocytes and urine, J. Clin. Chem. Clin. Biochem. 16:407 (1978).

    Google Scholar 

  14. M. Driessen, G. Weitz, E. M. Brouwer-Kelder, W. E. Donker-Koopman, J. Bastiaannet, K. Sandhoff, J. A. Barranger, J. M. Tager and A. W. Schram, The effect of detergents on immunoprecipitability of lysosomal sphingomyelinase. BBA 841:97 (1985).

    PubMed  CAS  Google Scholar 

  15. G. Weitz, L. E. Quintern, A. W. Schram, J. A. Barranger, J. M. Tager and K. Sandhoff, Purification and properties of acid sphingomyelinase from huma urine, in: “Enzymes of Lipid Metabol. II”, L. Freysz, H. Dreyfus, R. Massarelli and S. Gatt, eds., Plenum Press, New York, London, 261–266 (1986)

    Google Scholar 

  16. B. G. Rao and M. W. Spence, Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0, J. Lip. Res. 17:506 (1976).

    CAS  Google Scholar 

  17. J.W. Callahan, C. S. Jones, D. J. Davidson and P. Shankaran, The active site of lysosomal sphingomyelinase: Evidence for the involvement of hydrophobic and ionic groups. J. Neurose. Res. 10:151 (1983).

    Article  CAS  Google Scholar 

  18. C. S. Jones, P. Shankaran, D. J. Davidson, A. Poulos and J. W. Callahan, Studies on the structure of sphingomyelinase: Amino acid composition and heterogeneity on isoelectric focusing, Biochem. J. 209:291 (1983).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this paper

Cite this paper

Quintern, L.E., Nehrkorn, H., Sandhoff, K., Weitz, G., Tager, J.M., Schram, A.W. (1988). Acid Sphingomyelinase from Human Urine: Purification and Characterisation. In: Salvayre, R., Douste-Blazy, L., Gatt, S. (eds) Lipid Storage Disorders. NATO ASI Series, vol 150. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1029-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1029-7_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8300-3

  • Online ISBN: 978-1-4613-1029-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics